Aug. 23, 2013News & Opinions
Onyx Pharmaceuticals has given potential buyers, including Amgen, access to trial data on its new cancer drug, removing a key hurdle that was holding up deal talks, according to three people familiar with the matter.
Jul. 18, 2013News & Opinions
Chinese authorities investigating the alleged bribery of doctors and officials by GlaxoSmithKline have stopped the drugmaker's head of finance for China, a British citizen, from leaving the country, a company spokesman said on Wednesday.
Jul. 01, 2013News & Opinions
European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis.
Jun. 20, 2013News & Opinions
European antitrust regulators fined nine drugmakers, including Denmark's Lundbeck, a total of €146 million ($195 million) for blocking the supply of a cheaper anti-depressant to the market, the first EU sanction against such deals.
Jun. 18, 2013News & Opinions
Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment ...
Jun. 06, 2013News & Opinions
Inspired by its success in high-tech electronics and software, Israel is hoping to pull off the same trick in life sciences.
Jun. 03, 2013News & Opinions
A European regulator will fine Denmark's Lundbeck and eight other makers of generic drugs for limiting the supply of cheaper medicines, two people with knowledge of the matter said, its first sanction against "pay-for-delay" deals.
May. 23, 2013News & Opinions
Johnson & Johnson said it plans to seek approvals for 11 new drugs by 2017, including a new type of treatment for patients with depression that have failed to benefit from standard medications.
May. 07, 2013News & Opinions
A new generation of drug industry chief executives is stepping up plans to restructure their businesses by divesting slower-growing and maturing operations, opening up new opportunities for deal-makers.
May. 04, 2013News & Opinions
Health officials in India have revoked Johnson & Johnson's license to make cosmetics at a plant outside Mumbai after they discovered the company had used an unauthorized process for sterilizing its baby powder.
The latest information directly via newsletter.